← Open Payments lookup

MOLLY BROWN: Open Payments

NPI 1750158473 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$652 in 44 payments from 12 companies in 2025. Trend: 2023 $28 · 2024 $679 · 2025 $652

Food & beverage: $652
CompanyPaymentsAmount
ABBVIE INC.23$302
Novo Nordisk Inc4$66
Takeda Pharmaceuticals U.S.A., Inc.3$53
Lilly USA, LLC3$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$35
PFIZER INC.2$31
Otsuka America Pharmaceutical, Inc.1$24
AstraZeneca Pharmaceuticals LP1$22
Janssen Pharmaceuticals, Inc1$21
MAYNE PHARMA COMMERCIAL LLC2$20

Products named: UBRELVY, QULIPTA, VRAYLAR, TRINTELLIX, Wegovy, JARDIANCE, CAPLYTA, REXULTI.

Industry payments across NE — which companies pay providers there.